Glycopyrrolate/indacaterol (QVA149), glycopyrrolate, indacaterol, placebo and its effect in volunteers

Trial Profile

Glycopyrrolate/indacaterol (QVA149), glycopyrrolate, indacaterol, placebo and its effect in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Feb 2014

At a glance

  • Drugs Glycopyrrolate/indacaterol (Primary) ; Glycopyrrolate; Indacaterol; Salmeterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Feb 2014 Status changed from active, no longer recruiting to completed according to results published in the International Journal of Clinical Pharmacology and Therapeutics.
    • 29 May 2013 New trial record
    • 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top